L.A. Dawson et al
Chronic effects of fluoxetine+ (+)pindolol
803
BLIER, P. & BERGERON, R. (1995). Eectiveness of pindolol with
selected antidepressant drugs in the treatment of major
depression. J. Clin. Psychopharmacol., 15, 217 ± 222.
BLIER, P. & DE MONTIGNY, C. (1994). Current advances and trends
in the treatment of depression. Trends Pharmacol. Sci., 15, 220 ±
226.
GOBERT, A. & MILLAN, M.J. (1999). Modulation of dialysate levels
of dopamine, noradrenaline and serotonin (5-HT) in the frontal
cortex of freely moving rats by (7)-pindolol alone and in
association with 5-HT reuptake inhibitors: comparative roles of
b-adrenergic, 5-HT1A and 5-HT1B receptors. Neuropsychophar-
macology, 21, 268 ± 284.
BLIER, P., DE MONTIGNY, C. & CHAPUT, Y. (1987). Modi®cations of
the serotonin system by antidepressant treatments: implications
for the therapeutic response in major depression. J. Clin.
Psychopharmacol., 7, 24 ± 35.
BORDET, R., THOMAS, P. & DUPUIS, B. (1998). Eect of pindolol on
onset of action of paroxetine in the treatment of major
depression: intermediate analysis of a double-blind, placebo-
controlled trial. Am. J. Psychiatry, 155, 1346 ± 1351.
GOBERT, A., RIVET, J.-M., CISTARELLI, L. & MILLAN, M.J. (1997).
Potentation of the ¯uoxetine-induced increase in the frontal
cortex of freely moving rats by combined blockade of 5-HT1A
and 5-HT1B receptors with WAY100635 and GR127935. J.
Neurochem., 68, 1159 ± 1163.
GUNDLAH, C., HJORTH, S. & AUERBACH, S.B. (1997). Autoreceptor
antagonists enhance the eect of the reuptake inhibitor
citalopram on extracellular 5-HT: the eect persists after
repeated citalopram treatment. Neuropharmacology, 36, 475 ±
482.
BOSKER, F.J., VAN ESSEVELDT. K.E., KLOMPMAKERS, A.A.
&
WESTENBERG, H.G.M. (1995). Chronic treatment with ¯uvox-
amine by osmotic minipumps fails to induce persistent functional
changes in central 5-HT1A and 5-HT1B receptors, as measured by
in vivo microdialysis in dorsal hippocampus of conscious rats.
Psychopharmacology, 117, 358 ± 363.
HAJOS, M., HAJOS-KORCSOK, E. & SHARP, T. (1999). Role of the
medial prefrontal cortex in 5-HT1A receptor-induced inhibition
of 5-HT neuronal activity in the rat. Br. J. Pharmacol., 126,
1741 ± 1750.
BOURIN, M., REDROBE, J.P. & BAKER, G.B. (1998). Pindolol does
not act on 5-HT1A receptors in augmenting antidepressant
activity in the mouse forced swimming test. Psychopharmacology,
136, 226 ± 234.
HERVAS, I., VILARO, M.T., MENGOD, G. & ARTIGAS, F. (1999).
Modulation of the density and sensitivity of 5-HT1A autorecep-
tors by prolonged treatment with ¯uoxetine alone or with
WAY100635. Soc. Neurosci. Abstr., 24, 687.12.
CASANOVAS, J.P., HERVAS, I. & ARTIGAS, F. (1999). Postsynaptic 5-
HT1A receptors control 5-HT release in the rat medial prefrontal
cortex. Neuroreport, 10, 1441 ± 1445.
CECI, A., BASCHIROTTO, A. & BORSINI, F. (1994). The inhibitory
eect of 8-OH-DPAT on the ®ring activity of dorsal raphe
serotoninergic neurons in rats is attenuated by lesion of the
frontal cortex. Neuropharmacology, 33, 709 ± 713.
HJORTH, S. (1993). Serotonin 5-HT1A autoreceptor blockade
potentiates the ability of the 5-HT reuptake inhibitor citalopram
to increase nerve terminal output of 5-HT in vivo: a microdialysis
study. J. Neurochem., 60, 776 ± 779.
HJORTH, S. (1996). (7) Pindolol, but not buspirone, potentiates the
citalopram-induced rise in extracellular 5-hydroxytryptamine.
Eur. J. Pharmacol., 303, 183 ± 186.
CHAPUT, Y., BLIER, P. & DE MONTIGNY, C. (1986). Eects of a
selective 5-HT reuptake blocker, citalopram, on the sensitivity
of 5-HT autoreceptors: electrophysiological studies in the rat
brain. Naunyn-Schmeideberg's Arch. Pharmacol., 333, 342 ±
348.
HJORTH, S. & AUERBACH, S.B. (1994). Lack of 5-HT1A autoreceptor
desensitization following chronic citalopram treatment, as
determined by in vivo microdialysis. Neuropharmacology, 33,
331 ± 334.
HJORTH, S. & AUERBACH, S.B. (1996). 5-HT1A autoreceptors and
the mode of action of selective serotonin reuptake inhibitors
(SSRI). Behav. Brain Res., 73, 281 ± 283.
CLIFFORD, E.M., GARTSIDE, S.E., UMBERS, V., COWEN, P.J.,
& SHARP, T. (1998). Electrophysiological and
HAJOS, M.
neurochemical evidence that pindolol has agonist properties at
the 5-HT1A autoreceptor in vivo. Br. J. Pharmacol., 124, 206 ±
212.
HJORTH, S., BENGTSSON, H.J. & MILANO, S. (1996). Raphe 5-HT1A
autoreceptors, but not postsynaptic 5-HT1A receptors or b-
adrenoceptors, restrain the citalopram-induced increase in
extracellular 5-hydroxytryptamine in vivo. Eur. J. Pharmacol.,
316, 43 ± 47.
HJORTH, S. & CARLSSON, A. (1985). (7)-Pindolol stereo speci®cally
inhibits rat brain serotonin (5-HT) synthesis. Neuropharmacol-
ogy, 24, 1143 ± 1146.
HJORTH, S. & CARLSSON, A. (1986). Is pindolol a mixed agonist-
antagonist at central serotonin (5-HT) receptors?. Eur. J.
Pharmacol., 129, 131 ± 138.
HJORTH, S. WESTLIN, D. & BENGTSSON, H.J. (1997). WAY100635-
induced augmentation of the 5-HT-elevating action of citalo-
pram: relative importance of the dose of the 5-HT1A (auto)
receptor blocker versus that of the 5-HT reuptake inhibitor.
Neuropharmacology, 36, 461 ± 465.
INVERNIZZI, R., BRAMANTE, M. & SAMANIN, R. (1994). Chronic
treatment with citalopram facilitates the eect of a challenge dose
on cortical serotonin output: role of presynaptic 5-HT1A
receptors. Eur. J. Pharmacol., 260, 243 ± 246.
INVERNIZZI, R., BRAMANTE, M. & SAMANIN, R. (1996). Role of 5-
HT1A receptors in the eects of acute and chronic ¯uoxetine on
extracellular serotonin in the frontal cortex. Pharmacol. Biochem.
Behav., 54, 143 ± 147.
DAWSON, L.A. & NGUYEN, H.Q. (1998). Eects of 5-HT1A receptor
antagonists on ¯uoxetine-induced changes in serotonin in rat
frontal cortex. Eur. J. Pharmacol., 345, 41 ± 46.
DAWSON, L.A. & NGUYEN, H.Q. (2000). The role of 5-HT1A and 5-
HT1B/1D receptors on the modulation of acute ¯uoxetine-induced
changes in extracellular 5-HT: the mechanism of action of (+)
pindolol. Neuropharmacology, 39, 1044 ± 1052.
DAWSON, L.A. & ROUTLEDGE, C. (1996). Dierential eects of
potassium channel blockers on extracellular levels of serotonin
and dopamine in the striatum of conscious rats. Br. J.
Pharmacol., 116, 3260 ± 3264.
DAWSON, L.A., NGUYEN, H.Q., SMITH, D.L. & SCHECHTER, L.E.
(1998). Eects of chronic ¯uoxetine treatment, in the presence
and absence of 5-HT1A receptor blockade, on extracellular
concentrations of 5-HT: a microdialysis study. Soc. Neurosci.
Abstr., 24, 438.11.
DRESHFIELD, L.J., WONG, D.T., PERRY, K.W. & ENGLEMAN, E.A.
(1996). Enhancement of ¯uoxetine-dependent serotonin (5-HT)
levels by (7) pindolol, an antagonist at 5-HT1A receptors.
Neurochem. Res., 21, 557 ± 562.
FORNAL, C.A., MARTIN, F.J., METZLER, C.W.
& JACOBS, B.L.
(1999). Pindolol suppresses serotonergic neuronal activity and
does not block the inhibition of serotonergic neurons produced
by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats. J.
Pharmacol. Exp. Ther., 291, 229 ± 238.
LE POUL, E., LAARIS, N., DOUCET, E., LAPORTE, A.M., HAMON, M.
& LANFUMEY, L. (1995). Early desensitization of somatoden-
dritic 5-HT1A autoreceptors in rats treated with ¯uoxetine or
paroxetine. Naunyn-Schmeidebergs Arch. Pharmacol., 352, 141 ±
148.
GARDIER, A.M., MALAGIE, I., TRILLAT, A.C., JACQUOT, C.
&
ARTIGAS, F. (1996). Role of 5-HT1A autoreceptors in the
mechanism of action of serotonergic antidepressant drugs: recent
®ndings from in vivo microdialysis studies. Fundam. Clin.
Pharmacol., 10, 16 ± 27.
LI, Q., MUMA, N.A. & VAN DE KAR L.D. (1996). Chronic ¯uoxetine
induces a gradual desensitization of 5-HT1A receptors: reduc-
tions in hypothalamic and midbrain Gi and G(o) proteins and in
neuroendocrine responses to a 5-HT1A agonist. J. Pharmacol.
Exp. Ther., 279, 1035 ± 1042.
GARTSIDE, S.E., UMBERS, V., HAJOS, M.
& SHARP, T. (1995).
Interaction between a selective 5-HT1A receptor antagonist and
an SSRI in vivo: eects on 5-HT cell ®ring and extracellular 5-
HT. Br. J. Pharmacol., 115, 1064 ± 1070.
MCASKILL, R., MIR, S. & TAYLOR, D. (1998). Pindolol augmentation
of antidepressant therapy. Br. J. Psychiatry, 173, 203 ± 208.
PAXINOS, G. & WATSON, C. (1986). The rat brain in stereotaxic
coordinates. Academic Press, New York.
PEREZ, V., GILABERTE, I., FARIES, D., ALVAREZ, E. & ARTIGAS, F.
(1997). Randomized, double-blind, placebo-controlled trial of
pindolol in combination with ¯uoxetine antidepressant treat-
ment. Lancet, 349, 1594 ± 1597.
GOBBI, M., CRESPI, D., FODDI, M.C., FRACASSO, C., MANCINI, L.,
PAROTTI, L. & MENNINI, T. (1997). Eects of chronic treatment
with ¯uoxetine and citalopram on 5-HT uptake, 5-HT1B
autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn-
Schmiedeberg's Arch. Pharmacol., 356, 22 ± 28.
British Journal of Pharmacology, vol 130 (4)